Lupagen
David Peritt is the Founder and CSO of Lupagen, a company focused on creating a closed loop autologous cell modification system for bedside cell therapy. In addition, David serves as an Adjunct Professor at Northwestern University's McCormick School of Engineering and is a member of various science and technology committees. Peritt has held key roles at companies like Sigilon Therapeutics, Pfizer, and Hospira, with a background in immunology and a Ph.D. from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Lupagen
Lupagen team of engineers and immunologists developed and brought to market revolutionary bedside point-of-care cell therapies. The company developing cell and gene therapy delivery technologies for next-generation CAR-T, gene editing and immunotherapy products based on their patent-pending bedside, closed-loop, point-of-care technology.